[
  {
    "id": "fc_asthma_management_c5554fd0",
    "front": "Inhaled vasodilators: primary physiological benefit?",
    "back": "Improved hypoxemia, lower PAP, better RV function",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_5ec0b0ba",
    "front": "Inhaled prostacyclin vs NO?",
    "back": "Physiologically effective, less costly than Inhaled NO",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_1fd1f1dc",
    "front": "Inhaled vasodilators: proven mortality benefit?",
    "back": "No, not proven; no role for routine use",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_aff177d1",
    "front": "Inhaled vasodilators improve V/Q how?",
    "back": "Dilate vessels to functioning alveoli, recruit blood flow",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_296f978f",
    "front": "Inhaled vasodilator response: significant PaO2/FiO2?",
    "back": "Increase by 10%",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_63859ece",
    "front": "Inhaled vasodilators: mortality benefit?",
    "back": "Not proven; no routine use.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_e2373bdf",
    "front": "ECCO2R: main purpose?",
    "back": "Removes CO2; enables ultraprotective LPV.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_bc351b5a",
    "front": "Group 3 PH etiology?",
    "back": "Lung diseases and/or hypoxia",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_77fc226c",
    "front": "Group 3 PH: Lung disease types?",
    "back": "Obstructive, restrictive, mixed, developmental lung disorders",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_65f0113b",
    "front": "Hypoxia without lung disease: which PH group?",
    "back": "Group 3 PH",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_4229d588",
    "front": "Scleroderma: Group 3 PH due to?",
    "back": "Underlying interstitial lung disease",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_a143e19c",
    "front": "Group 3 PH: directed medical therapy?",
    "back": "No. Limited specific medical options.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_ff17086f",
    "front": "Group 3 PH caused by?",
    "back": "Lung diseases and/or hypoxia",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_4ac29d8b",
    "front": "Obstructive lung disease: Which PH group?",
    "back": "Group 3 PH (e.g., COPD)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_bca8a7a3",
    "front": "Restrictive lung disease: Which PH group?",
    "back": "Group 3 PH (e.g., ILD)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_efeb02c5",
    "front": "Hypoxia without lung disease: Which PH group?",
    "back": "Group 3 PH",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_fbeece70",
    "front": "Scleroderma ILD leads to which PH group?",
    "back": "Group 3 PH (due to underlying ILD)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  },
  {
    "id": "fc_asthma_management_c4f69f09",
    "front": "Group 3 PH: common causes?",
    "back": "Obstructive, restrictive, mixed lung disease; hypoxia; developmental disorders.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Asthma - Management and Step Therapy",
    "bookId": "asthma_management",
    "sourceSection": "GINA UPDATE",
    "sourceLocation": {
      "bookName": "12.Asthma mx 2 (1)",
      "chapter": "Steroid resistant asthma",
      "section": "GINA UPDATE",
      "pageNumber": 9
    }
  }
]